Unknown

Dataset Information

0

Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.

ABSTRACT:

SUBMITTER: Chong Y 

PROVIDER: S-EPMC8527596 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Contrasting specific antibody response to BNT162b2 mRNA vaccination in SARS-CoV-2-naive and previously infected nursing home residents.

Chong Yong Y   Tani Naoki N   Goto Takeyuki T   Yonekawa Akiko A   Ikematsu Hideyuki H   Shimono Nobuyuki N   Tanaka Yosuke Y   Akashi Koichi K  

The Journal of infection 20211020 3

Similar Datasets

Unknown Pronounced antibody elevation after SARS-CoV-2 BNT162b2 mRNA booster vaccination in nursing home residents.
| S-EPMC9530588 | biostudies-literature
Unknown COVID-19 mRNA booster vaccination induces robust antibody responses but few adverse events among SARS-CoV-2 naive nursing home residents.
| S-EPMC11458568 | biostudies-literature
Unknown Humoral Responses to Single-Dose BNT162b2 mRNA Vaccination in Dialysis Patients Previously Infected With SARS-CoV-2.
| S-EPMC8415834 | biostudies-literature
Unknown Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents.
| S-EPMC8240817 | biostudies-literature
Unknown Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.
| S-EPMC9373891 | biostudies-literature
Unknown Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
| S-EPMC9402619 | biostudies-literature
Unknown Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naive and previously infected individuals.
| S-EPMC8754698 | biostudies-literature
Unknown mRNA vaccination drives differential mucosal neutralizing antibody profiles in naive and SARS-CoV-2 previously-infected individuals.
| S-EPMC9499336 | biostudies-literature
Unknown Different decay of antibody response and VOC sensitivity in naive and previously infected subjects at 15 weeks following vaccination with BNT162b2.
| S-EPMC8742572 | biostudies-literature
Unknown Dynamics of SARS-CoV-2 IgG in Nursing Home Residents in Belgium Throughout Three BNT162b2 Vaccination Rounds: 19-Month Follow-Up
| S-EPMC12030799 | biostudies-literature